// App-Quantinova.ai

: Raised FeNO in optimally-treated severe asthma identifies persistent eosinophilic chemotactic pull towards the airway

Researchers

Presenter

  • Simon Couillard

Principal Investigators

  • Rahul Shrimanker

  • Gareth Hynes

  • Catherine Borg

  • Clare Connolly

  • Anna Hayman

  • Samantha Thulborn

  • Angela Moran

  • Sarah Poole

  • Timothy Powell

  • Rekha Chaudhuri

  • Adel H Mansur

  • Lorcan P Mcgarvey

  • Liam G Heaney

  • Stephen Fowler

  • Peter Bradding

  • Ian D Pavord

  • Timonthy S C Hinks

Medical Centers

  • Division of Infection, Inflammation and Respiratory Medicine, University of Manchester, Manchester, United Kingdom,

  • Oxford Respiratory NIHR Biomedical Research Centre, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom

  • University of Birmingham and Heartlands Hospital, University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom

  • Centre for Experimental Medicine, Queen’s University Belfast, School of Medicine, Dentistry and Biomed, Belfast, UK

  • Institute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow, UK

  • Centre for Experimental Medicine, Queen’s University Belfast School of Medicine Dentistry and Biomedical Sciences, Oxford, United Kingdom

  • Department of Respiratory Sciences, University of Leicester and NIHR BRC, Leicester, Leicester, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Asthma

Biomarkers

  • C-C Motif Chemokine Ligand 26

  • Prostaglandin D2

  • Leukotriene E4

  • Interleukin 4

  • Tumor necrosis factor

Drug/Treatment

  • Interferon Gamma

  • IL-4

Outcome

  • N/A

Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved